Citigroup
INO icon

Citigroup’s Inovio Pharmaceuticals INO Stock Holding History

Citigroup’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,175
Closed -$762K – 6807
2020
Q4 		$762K Sell
7,175
-175
-2% -$23.3K ﹤0.01% 3818
2020
Q3 		$1.02M Buy
7,350
+2,567
+54% +$535K ﹤0.01% 3257
2020
Q2 		$1.55M Buy
4,783
+2,533
+113% +$407K ﹤0.01% 3109
2020
Q1 		$201K Buy
2,250
+2,067
+1,130% +$127K ﹤0.01% 4736
2019
Q4 		$7K Buy
183
+25
+16% +$752 ﹤0.01% 7305
2019
Q3 		$4K Sell
158
-142
-47% -$4.32K ﹤0.01% 7390
2019
Q2 		$11K Buy
300
+133
+80% +$5.28K ﹤0.01% 7278
2019
Q1 		$7K Sell
167
-491
-75% -$24.7K ﹤0.01% 7342
2018
Q4 		$32K Sell
658
-150
-19% -$9.11K ﹤0.01% 6573
2018
Q3 		$54K Sell
808
-159
-16% -$8.85K ﹤0.01% 6459
2018
Q2 		$45K Buy
967
+484
+100% +$26.7K ﹤0.01% 6367
2018
Q1 		$27K Buy
483
+175
+57% +$9.47K ﹤0.01% 6570
2017
Q4 		$15K Sell
308
-200
-39% -$12.4K ﹤0.01% 6865
2017
Q3 		$39K Sell
508
-84
-14% -$6.25K ﹤0.01% 6123
2017
Q2 		$56K Buy
592
+509
+613% +$43.5K ﹤0.01% 5708
2017
Q1 		$7K Sell
83
-309
-79% -$24.6K ﹤0.01% 6689
2016
Q4 		$33K Sell
392
-41
-9% -$3.71K ﹤0.01% 6330
2016
Q3 		$48K Sell
433
-242
-36% -$26.7K ﹤0.01% 5683
2016
Q2 		$75K Buy
675
+508
+304% +$61.7K ﹤0.01% 5308
2016
Q1 		$17K Buy
+167
New +$12.9K ﹤0.01% 6612

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup's INO Position: Q4 2025 in Review

Citigroup sold out of Inovio Pharmaceuticals (INO) in Q4 2025, closing a stake of 12,977 shares — an estimated $30.4K sold.

Citigroup first reported a position in INO in Q2 2013 and held it in 50 quarters. The position peaked at $7.39M in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q4 2025.

  • Citigroup reported no remaining Inovio Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 12,977 Inovio Pharmaceuticals shares in Q4 2025, an estimated $30.4K.
  • Citigroup first reported a position in Inovio Pharmaceuticals in Q2 2013 and held it in 50 quarters.
  • Citigroup's Inovio Pharmaceuticals position peaked at $7.39M in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.